New York, NY (PRWEB) June 01, 2012
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed lawsuits on behalf of a Texas woman (Case No. 3:12-cv-10934-DRH-PMF) and a Massachusetts woman (Case No. 3:12-cv-10935-DRH-PMF) who allegedly developed deep vein thrombosis and other injuries as a result of taking Yaz, its predecessor Yasmin or the generic Ocella. Both cases were filed in the multidistrict litigation on May 29th in the U.S. District Court for the Southern District of Illinois before Judge David R. Herndon (MDL. No 2100).
According to the complaints, both women developed deep vein thrombosis after taking Yaz, Yasmin or Ocella. The suits allege severe and permanent personal injuries, pain, suffering and emotional distress. The complaints further allege that the Plaintiffs would not have suffered these effects if Bayer had properly warned about the risks.
The lawsuits allege that Bayer failed to perform sufficient safety tests, exposing users to an increased risk of serious side effects, such as
- Heart arrhythmias
- Myocardial infarction
- Transient ischemic attack
- Blood clots
- Kidney and gallbladder disease and/or sudden death
According to the complaints, the injuries are permanent and lasting in nature; plaintiffs endure physical pain and mental anguish, diminished enjoyment of life, a future of high risk pregnancies and other complications.
The U.S. Food and Drug Administration (FDA) approved Yasmin in 2001 as a combined oral contraceptive. Yaz gained approval in 2006. According to Parker Waichman, the two birth control pills are almost exactly alike, except Yasmin contains slightly more estrogen. Yaz and Yasmin both contain drospirenone, which has not been used in previous oral contraceptives and may increase the risk of blood clots.
In 2008, the FDA contacted Bayer regarding its misleading Yaz advertisements. The agency stated in a warning letter that the TV commercials incorrectly touted Yaz as an effective way to treat all types of acne and premenstrual syndrome (PMS) while failing to properly warn about the risks. Bayer produced a $20 million corrective campaign in 2009. [nytimes.com/2009/02/11/business/11pill.html]
Last December, former FDA commissioner David Kessler issued a report stating that Bayer omitted data in order to hide the risks of Yasmin. [bloomberg.com/news/2011-12-05/bayer-withheld-yasmin-clot-risk-data-from-u-s-ex-agency-head-tells-court.html]
In April, the FDA updated the information of drospirenone-based birth controls. According to the Drug Safety Communication, clinical studies showed that the risk of blood clots may be three times as high in Yaz and Yasmin users. http://www.fda.gov/Drugs/DrugSafety/ucm299305.htm
Parker Waichman offers free legal evaluations to the victims of drospirenone contraceptives, including Yaz and Yasmin. If you or a loved one has suffered blood clots, deep vein thrombosis (DVT), pulmonary embolism, gallbladder disease/removal, stroke, death and other serious injuries while taking one of these birth control pills, please visit the firm's Yaz and Yasmin injury page at http://www.yourlawyer.com.
About Parker Waichman LLP
Parker Waichman LLP is a leading personal injury law firm that represents plaintiffs nationwide. The firm has offices in New York, New Jersey, Florida and Washington, D.C. For more than two decades, Parker Waichman LLP has assisted thousands of clients in receiving fair compensation due to the negligence of others and injuries resulting from defective drugs, medical devices and other products.
For more information on Parker Waichman LLP, please visit: http://www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney